Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Change in Taxes (2016 - 2025)

Kiora Pharmaceuticals' Change in Taxes history spans 11 years, with the latest figure at $338788.0 for Q4 2025.

  • For Q4 2025, Change in Taxes fell 85.27% year-over-year to $338788.0; the TTM value through Dec 2025 reached $1.5 million, up 156.2%, while the annual FY2025 figure was $1.5 million, 191.36% up from the prior year.
  • Change in Taxes reached $338788.0 in Q4 2025 per KPRX's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $2.3 million in Q4 2024 to a low of -$2.1 million in Q3 2024.
  • Average Change in Taxes over 5 years is $182289.4, with a median of $162939.0 recorded in 2021.
  • Peak YoY movement for Change in Taxes: skyrocketed 10723.0% in 2021, then tumbled 1585.03% in 2025.
  • A 5-year view of Change in Taxes shows it stood at $106100.0 in 2021, then crashed by 68.43% to $33497.0 in 2022, then skyrocketed by 1479.58% to $529113.0 in 2023, then soared by 334.69% to $2.3 million in 2024, then tumbled by 85.27% to $338788.0 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Change in Taxes are $338788.0 (Q4 2025), $1.2 million (Q3 2025), and $208020.0 (Q2 2025).